News Releases Year: - Any -202020192018201720162015201420132012 Items per page 102550 02/05/20 Summary ToggleClearside Biomedical Announces Presentations to be Given at Angiogenesis and Macula Society Conferences PDF Version 01/28/20 Summary ToggleBausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology PDF Version 01/06/20 Summary ToggleClearside Biomedical to Present at the 38th Annual J.P. Morgan Healthcare Conference PDF Version 11/13/19 Summary ToggleClearside Biomedical to Present at the Stifel 2019 Healthcare Conference PDF Version 11/06/19 Summary ToggleClearside Biomedical Announces Third Quarter 2019 Financial Results and Provides Corporate Update PDF Version 10/30/19 Summary ToggleClearside Biomedical to Report Third Quarter 2019 Financial Results and Provide Corporate Update on Wednesday, November 6, 2019 PDF Version 10/30/19 Summary ToggleClearside Biomedical Announces Option Exercise by REGENXBIO for Global License for Use of SCS Microinjector™ in AAV Gene Therapy Delivery PDF Version 10/23/19 Summary ToggleBausch Health Licenses Clearside Biomedical's XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis PDF Version 10/17/19 Summary ToggleClearside Biomedical Suprachoroidal Injection Platform Featured in Multiple Presentations at the American Academy of Ophthalmology (AAO) 2019 Annual Meeting PDF Version 10/03/19 Summary ToggleClearside Biomedical Announces Multiple Presentations to be Given at the American Academy of Ophthalmology (AAO) 2019 Annual Meeting PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 Next page Last page Last
